Pfizer is Likely to Halt It’s Phase 3 Trial of a Treatment for Recurrent Kidney Cancer Following Disappointing Results
Source: Pixabay

Pfizer is Likely to Halt It’s Phase 3 Trial of a Treatment for Recurrent Kidney Cancer Following Disappointing Results

The phase 3 trial of the drug Inlyta for the treatment of patients with a high risk of recurrent renal cell carcinoma (kidney cancer) following nephrectomy (removal of a kidney)…

Continue Reading Pfizer is Likely to Halt It’s Phase 3 Trial of a Treatment for Recurrent Kidney Cancer Following Disappointing Results
A Groundbreaking Marijuana-Derived Treatment is Getting Closer to FDA Approval for Treating Rare Forms of Epilepsy
source: pixabay.com

A Groundbreaking Marijuana-Derived Treatment is Getting Closer to FDA Approval for Treating Rare Forms of Epilepsy

According to a story from statnews.com, a drug derived from substances originating in the cannabis plant may be nearing approval by the U.S. Food and Drug Administration. The drug is…

Continue Reading A Groundbreaking Marijuana-Derived Treatment is Getting Closer to FDA Approval for Treating Rare Forms of Epilepsy
Devan Demmons and Service Dog Duke Make Pageant History while Raising Awareness about Dysautonomia
source: pixabay.com

Devan Demmons and Service Dog Duke Make Pageant History while Raising Awareness about Dysautonomia

The 2018 Mrs. Maine International Pageant will be so much more than a celebration of poise and beauty. It will also make history when Devan Demmons will proudly walk on…

Continue Reading Devan Demmons and Service Dog Duke Make Pageant History while Raising Awareness about Dysautonomia
Delaying Epilepsy Onset in Young Children Could Improve Other Neurological Conditions
1041483 / Pixabay

Delaying Epilepsy Onset in Young Children Could Improve Other Neurological Conditions

Scientists are investigating whether delaying the onset of epilepsy in very young children could reduce or prevent other neurological conditions such as learning difficulties and autism, reports Medical Xpress. This…

Continue Reading Delaying Epilepsy Onset in Young Children Could Improve Other Neurological Conditions
A Drug for Still’s Disease Has Been Approved in Europe
Source: Pixabay

A Drug for Still’s Disease Has Been Approved in Europe

A drug called Kineret has been approved by the European Commission in 28 European countries for the treatment of both adult-onset and juvenile-onset Still’s disease, reports Check Orphan. Still’s disease…

Continue Reading A Drug for Still’s Disease Has Been Approved in Europe
New Drug Gains Approval For Treating X-Linked Hypophosphatemia in the U.S.
source: pixabay.com

New Drug Gains Approval For Treating X-Linked Hypophosphatemia in the U.S.

According to a story from globenewswire.com, the pharmaceutical companies Ultragenyx and Kyowa Kirin recently issued an announcement that the U.S. FDA has granted approval to their new treatment Crysvita (burosumab-twza).…

Continue Reading New Drug Gains Approval For Treating X-Linked Hypophosphatemia in the U.S.
A Potential Gene Therapy for Duchenne Muscular Dystrophy Has Just Begun Patient Testing
Source: Pixabay

A Potential Gene Therapy for Duchenne Muscular Dystrophy Has Just Begun Patient Testing

Pfizer has just begun a medical trial for a potential gene therapy treatment for Duchenne muscular dystrophy, and the first patient has been dosed. Click here to read the original…

Continue Reading A Potential Gene Therapy for Duchenne Muscular Dystrophy Has Just Begun Patient Testing